107 träffarepidemiology

news aktuell GmbH

Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment10.4.2024 11:00:00 CEST | news aktuell GmbH | Press Release

The launch in Germany through its step-down subsidiary betapharm marks Dr. Reddy's entry into digital therapeutics in Europe. Nerivio® is the first REN (wearable, FDA-cleared, and CE-marked for acute and/or prevention migraine (with or without aura) treatment for adults and adolescents (≥ 12 years). Nerivio® is worn on the upper arm during treatment and controlled by a smartphone app, making it comfortable and portable. Starting with Germany, followed by Spain and the UK, Dr. Reddy's plans to further increase access to Nerivio® in European countries.
Karolinska Institutet - English

Patients with treatment resistant depression at higher risk of death14.12.2022 16:00:00 CET | Karolinska Institutet - English | Press Release

Patients with treatment resistant depression have a 23 per cent higher risk of death than other depressed patients. They also have twice as much outpatient care and spend three times the number of days in inpatient care. These are findings of a new study published in JAMA Psychiatry by researchers from Karolinska Institutet and elsewhere, who conclude that it is important to identify patients at risk of developing treatment resistant depression.
Karolinska Institutet - English

Adult ADHD linked to elevated risk of cardiovascular diseases15.9.2022 11:00:00 CEST | Karolinska Institutet - English | Press Release

Adults with ADHD are at greater risk of developing a range of cardiovascular diseases than those without the condition, according to a large observational study led by researchers at Karolinska Institutet and Örebro University in Sweden. The researchers say the findings, published in the journal World Psychiatry, underscore the need to monitor cardiovascular health in people with ADHD.
Karolinska Institutet - English

New study reveals differences in care of chronic kidney disease between women and men1.8.2022 09:00:00 CEST | Karolinska Institutet - English | Press Release

Women with reduced kidney function received a diagnosis of chronic kidney disease to a less extent than men in the same situation. Women were also less likely to have their kidney function monitored, to visit a nephrologist and to use recommended treatments for chronic kidney disease. This according to a new study by researchers from Karolinska Institutet in Sweden published in the Journal of the American Society of Nephrology.
Statens veterinärmedicinska anstalt

Tongivande konferens inom veterinär epidemiologi till Uppsala 202423.3.2022 07:15:00 CET | Statens veterinärmedicinska anstalt | Pressmeddelande

Med missionen att förbättra hälsan hos djur, människor och miljön samlas årligen medlemmarna i SVEPM, Society for veterinary epidemiology and preventive medicine, för att utbyta erfarenheter och föra forskningen framåt. Det anrika sällskapet samlar veterinärer, biologer och virologer men även ekonomer, beteendevetare och matematiker som arbetar förebyggande med djurhälsa i gränslandet mellan vetenskap och policy.
Karolinska Institutet - English

Risks after treatment for cervical neoplasia have declined over time7.2.2022 22:00:00 CET | Karolinska Institutet - English | Press Release

The treatment of serious prodromal cervical cancer, CIN3, can cause problems during later pregnancy amongst women of fertile age. A new registry study from Karolinska Institutet shows a higher risk of several adverse pregnancy outcomes after such treatment, but the risks have declined over time and the increased risk of infant death no longer exists. The study, which included a large number of births in Sweden over a 46-year period, is published in The Annals of Internal Medicine.
Karolinska Institutet - English

Large international evaluation shows AI accurately diagnoses prostate cancer13.1.2022 16:01:00 CET | Karolinska Institutet - English | Press Release

Researchers at Karolinska Institutet in Sweden have together with international collaborators completed a comprehensive international validation of artificial intelligence (AI) for diagnosing and grading prostate cancer. The study, published in Nature Medicine, shows that AI systems can identify and grade prostate cancer in tissue samples from different countries equally well as pathologists. The results suggest AI systems are ready to be responsibly introduced as a complementary tool in prostate cancer care, researchers say.
Karolinska Institutet - English

New way of identifying early risk of cardiovascular disease1.12.2021 19:00:00 CET | Karolinska Institutet - English | Press Release

The risk of developing cardiovascular disease is strongly associated with the “bad” LDL cholesterol. A large study by scientists at Karolinska Institutet now shows that two proteins that transport cholesterol particles in the blood provide early and reliable risk information. The researchers advocate introducing new guidelines for detecting cardiac risk and say the results, published in PLOS Medicine, may pave the way for early treatment, which could help lower morbidity and fatality rates.
Karolinska Institutet - English

AI improves precision in breast cancer diagnosis29.9.2021 23:05:00 CEST | Karolinska Institutet - English | Press Release

Researchers at Karolinska Institutet in Sweden have developed an AI-based tool that improves the diagnosis of breast cancer tumours and the ability to predict the risk of recurrence. The greater diagnostic precision can lead to more personalised treatment for the large group of breast cancer patients with intermediate risk tumours. The results are published in the scientific journal Annals of Oncology.
  • 1
  • 2
  • 3
  • 4
  • 5
  • Sista
  • >>
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye